The insulin-like activity of cyclic nucleotides and their inhibition by caffeine on the isolated fat cells.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D002087:Butyrates / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000096:biosynthesis; D002247:Carbon Isotopes; D000242:Cyclic AMP / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D003597:Cytosine Nucleotides / Q000494:pharmacology; D003864:Depression, Chemical; D005947:Glucose / Q000378:metabolism*; D005990:Glycerol / Q000378:metabolism; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D007329:Insulin Antagonists; D050356:Lipid Metabolism; D008055:Lipids / Q000096:biosynthesis; D009711:Nucleotides / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013942:Thymine Nucleotides / Q000494:pharmacology; D014500:Uracil Nucleotides / Q000494:pharmacology
D000227:Adenine Nucleotides; D002087:Butyrates; D002247:Carbon Isotopes; D003597:Cytosine Nucleotides; D007328:Insulin; D007329:Insulin Antagonists; D008055:Lipids; D009711:Nucleotides; D013942:Thymine Nucleotides; D014500:Uracil Nucleotides; D002245:Carbon Dioxide; D002110:Caffeine; D000242:Cyclic AMP; D006152:Cyclic GMP; D005947:Glucose; D005990:Glycerol